sodium salicylate has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, ST; Ho, DW; Poon, RT; To, J; Yang, ZF | 1 |
Mahmud, I; Miura, Y | 1 |
2 other study(ies) available for sodium salicylate and Liver Neoplasms
Article | Year |
---|---|
The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Hypoxia; Cisplatin; Combined Modality Therapy; Disease Progression; Hepatic Artery; HSP90 Heat-Shock Proteins; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Neoplasms; Male; Necrosis; Rats; Rats, Inbred BUF; Sodium Salicylate; Survival Rate; Transcription Factors; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Up-Regulation; Vascular Endothelial Growth Factor A; Von Hippel-Lindau Tumor Suppressor Protein | 2004 |
Effects of stimulators and inhibitors on arachidonic acid metabolism in hepatoma.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Butylated Hydroxytoluene; Carcinoma, Hepatocellular; Indomethacin; Liver Neoplasms; Prostaglandins; Rats; Sodium Salicylate; Thromboxane B2; Thromboxanes; Tryptophan | 1981 |